CRMP1 and amyotrophic lateral sclerosis: We examined the phosphorylation status of CRMP1 in the lumbar spinal cord of ALS patients by immunohistochemistry with the anti–pThr509-CRMP1 antibody, and detected immunoreactivity in ALS patients but rarely in disease controls (Figure 2A).